The authors of this On-Topic focus on the latest developments in the pharmaceutical sector. According to Ms Thill-Tayara, author of the first contribution and lawyer with Dechert Paris, if the competition agencies’ activism is partly motivated by the need to limit the expenses of national health (...)

This set of contributions presents the various competitive effects associated with minority shareholdings. It also considers how these effects can be dealt with either through notifications to the competition authority, especially with the case of the German and British legislations, or through (...)

La deuxième table-ronde de la conférence New Frontiers of Antitrust du 11 février 2011 à Paris est dédiée à la quantification des dommages dans les procedures civiles. Raphael de Coninck, membre de l’équipe du chef économiste de la Commission européenne, présente dans la première contribution, plusieurs (...)

This mini-symposium takes stock of practical advances in competition damage evaluation. Combining perspectives from competition authorities, academics and practitioners respectively, it shows the existence of common principles and a set of widely accepted methods to calculate damages that may (...)

In light of the European Commission’s recent initiatives to bolster private antitrust enforcement, this paper discusses the general economic framework for damages estimation, reviews common empirical methods used by economic experts and highlights some of the practical challenges for estimating (...)

On the 28th of November 2007, the Commission adopted the Non-Horizontal Merger Guidelines. This article illustrates how these guidelines are applied in practice by reviewing the economic analysis undertaken in Google/DoubleClick and TomTom/TeleAtlas, two recent mergers that raised (...)